Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Head and voice tremor improving with immunotherapy in an anti-155 positive patient

  • Painous, Cèlia|||0000-0002-7027-3093
  • López-Pérez, Mª Ángeles
  • Illa, Isabel|||0000-0002-2186-2684
  • Querol, Luis|||0000-0002-4289-8264
Chronic inflammatory demyelinating polyradiculoneuropathy with 155 antibodies (anti-155+) constitutes a specific chronic inflammatory demyelinating polyradiculoneuropathy subset with a high incidence of limb's tremor and poor response to conventional therapies. We report a patient with chronic inflammatory demyelinating polyradiculoneuropathy anti-155+ with a severe tremor involving limbs, head and voice that responded very well to rituximab. This response correlated with a sharp decrease in the anti-155 titers. This case is the first report associating head and voice tremor to chronic inflammatory demyelinating polyradiculoneuropathy, reinforces the hypothesis of the cerebellar origin of this tremor and provides indirect evidence that the antibodies may be the cause of the tremor in these patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15

  • Martinez Martinez, Laura
  • Lleixà, Cinta|||0000-0002-9971-0584
  • Boera-Carnicero, Gemma
  • Cortese, Andrea
  • Devaux, Jérôme|||0000-0001-6383-4334
  • Siles, Ana M..
  • Rajabally, Yusuf
  • Martínez-Piñeiro, Alicia|||0000-0003-1988-606X
  • Carvajal, Alejandra
  • Pardo, Julio|||0000-0001-8807-1310
  • Delmont, Emilien
  • Attarian, Shahram
  • Diaz-Manera, Jordi|||0000-0003-2941-7988
  • Callegari, Ilaria
  • Marchioni, Enrico
  • Franciotta, Diego
  • Benedetti, Luana
  • Lauria, Giuseppe
  • Calle Martín, Óscar de la|||0000-0001-9717-053X
  • Juárez Rubio, Cándido|||0000-0003-2235-9893
  • Illa, Isabel|||0000-0002-2186-2684
  • Querol, Luis|||0000-0002-4289-8264
Background: The aim of the research is to study the human leukocyte antigen (HLA) class II allele frequencies in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated with anti-neurofascin 155 (NF155) antibodies. Methods: Thirteen anti-NF155+ and 35 anti-NF155 negative (anti-NF155neg) CIDP patients were included in a casecontrol study. The frequencies of the DRB1 HLA allele were analyzed in all patients while DQ frequencies were only studied in patients sharing the DRB1*15 allele. In silico HLA-peptide binding and NF155 antigenicity, predictions were performed to analyze overlap between presented peptides and antigenic regions. Results: DRB1*15 alleles (DRB1*15:01 and DRB1*15:02) were present in 10 out of 13 anti-NF155+ CIDP patients and in only 5 out of 35 anti-NF155neg CIDP patients (77 vs 14%; OR = 20, CI = 4.035 to 99.13). DRB1*15 alleles appeared also in significantly higher proportions in anti-NF155+ CIDP than in normal population (77 vs 17%; OR = 16.9, CI = 4.434 to 57. 30). Seven anti-NF155+ CIDP patients (53%) and 5 anti-NF155neg CIDP patients had the DRB1*15:01 allele (OR = 7, p = 0.009), while 3 anti-NF155+ CIDP patients and none of the anti-NF155neg CIDP patients had the DRB1*15:02 allele (OR = 23.6, p = 0.016). In silico analysis of the NF155 peptides binding to DRB1*15 alleles showed significant overlap in the peptides presented by the 15:01 and 15:02 alleles, suggesting functional homology. Conclusions: DRB1*15 alleles are the first strong risk factor associated to a CIDP subset, providing additional evidence that anti-NF155+ CIDP patients constitute a differentiated disease within the CIDP syndrome.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Anti-neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo

  • Manso, Constance
  • Querol, Luis|||0000-0002-4289-8264
  • Lleixà, Cinta|||0000-0002-9971-0584
  • Poncelet, Mallory
  • Mekaouche, Mourad
  • Vallat, Jean-Michel
  • Illa, Isabel|||0000-0002-2186-2684
  • Devaux, Jérôme|||0000-0001-6383-4334
Neurofascin-155 (Nfasc155) is an essential glial cell adhesion molecule expressed in paranodal septate-like junctions of peripheral and central myelinated axons. The genetic deletion of Nfasc155 results in the loss of septate-like junctions and in conduction slowing. In humans, IgG4 antibodies against Nfasc155 are implicated in the pathogenesis of chronic inflammatory demyelinating polyneuropathy (CIDP). These antibodies are associated with an aggressive onset, a refractoriness to intravenous immunoglobulin, and tremor of possible cerebellar origin. Here, we examined the pathogenic effects of patient-derived anti-Nfasc155 IgG4. These antibodies did not inhibit the ability of Nfasc155 to complex with its axonal partners contactin-1 and CASPR1 or induce target internalization. Passive transfer experiments revealed that IgG4 antibodies targeted Nfasc155 on Schwann cell surfaces, and diminished Nfasc155 protein levels and prevented paranodal complex formation in neonatal animals. In adult animals, chronic intrathecal infusions of antibodies also induced the loss of Nfasc155 and of paranodal specialization and resulted in conduction alterations in motor nerves. These results indicate that anti-Nfasc155 IgG4 antibodies perturb conduction in the absence of demyelination, validating the existence of paranodopathy. These results also shed light on the mechanisms regulating protein insertion at paranodes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Antibodies to nodal/paranodal proteins in paediatric immune-mediated neuropathy

  • De Simoni, Desiree
  • Ricken, Gerda
  • Winklehner, Michael
  • Koneczny, Inga
  • Karenfort, Michael
  • Hustedt, Ulf
  • Seidel, Ulrich
  • Abdel-Mannan, Omar|||0000-0002-0796-9645
  • Munot, Pinki
  • Rinaldi, Simon|||0000-0003-2039-3457
  • Steen, Claudia
  • Freilinger, Michael
  • Breu, Markus|||0000-0003-3825-5749
  • Seidl, Rainer
  • Reindl, Markus|||0000-0003-2817-1402
  • Wanschitz, Julia|||0000-0002-0207-9977
  • Lleixà, Cinta|||0000-0002-9971-0584
  • Bernert, Günther
  • Wandinger, Klaus-Peter
  • Junker, Ralf
  • Querol, Luis|||0000-0002-4289-8264
  • Leypoldt, Frank
  • Rostásy, Kevin
  • Höftberger, Romana|||0000-0002-5769-1100
Dipòsit Digital de Documents de la UAB
Publication Otros (Other)

Excellent Response to Plasma Exchange in Three Patients With Enterovirus-71 Neurological Disease

  • Pascual-Goñi, Elba|||0000-0001-7336-4305
  • Josa, Maria
  • Launes, Cristian|||0000-0002-0913-9303
  • Querol, Luis|||0000-0002-4289-8264
  • del Cuerpo Casas, Margarita|||0000-0001-7973-5496
  • Bosch, M. Alba
  • Jordán García, Iolanda|||0000-0002-2041-4425
  • Turon Viñas, Eulalia|||0000-0001-6171-0282
The clinical spectrum of Enterovirus-71-associated neurological disease includes acute flaccid paralysis, encephalomyelitis, or brainstem encephalitis with autonomic dysfunction. As no specific antiviral treatments are available, intravenous human immunoglobulin is used in early stages of the illness, decreasing serum proinflammatory cytokines, and improving clinical outcomes. Plasma exchange aims to eliminate pathogenic autoantibodies and proinflammatory cytokines, and is used in diverse immune-mediated neurologic conditions. However, its effect in Enterovirus-71 infections is unknown. We report three cases of severe Enterovirus-71 neurological disease treated with plasma exchange during an outbreak in Catalonia (Spain) in 2016. We observed a striking improvement in all three patients within 48 h of starting plasma exchange. Patients received four to six sessions every other day. Good outcomes were confirmed at the 1-year follow-up visit. Our observations suggest that plasma exchange is an effective complementary therapy for severe Enterovirus-71 neurological disease.